참고문헌
- Al-Yacoub N, Fecker LF, Mobs M, et al (2012). Apoptosis induction by SAHA in cutaneous T-cell lymphoma cells is related to downregulation of c-FLIP and enhanced TRAIL signaling. J Invest Dermatol, 132, 2263-74. https://doi.org/10.1038/jid.2012.125
- Ammerpohl O, Thormeyer D, Khan Z, et al (2004). HDACi phenylbutyrate increases bystander killing of HSV-tk transfected glioma cells. Biochem Biophys Res Commun, 324, 8-14. https://doi.org/10.1016/j.bbrc.2004.09.016
- Darvas K, Rosenberger S, Brenner D, et al (2010). Histone deacetylase inhibitor-induced sensitization to TNFalpha/TRAIL-mediated apoptosis in cervical carcinoma cells is dependent on HPV oncogene expression. Int J Cancer, 127, 1384-92. https://doi.org/10.1002/ijc.25170
- Di Fiore A, Maresca A, Supuran CT, De Simone G (2012). Hydroxamate represents a versatile zinc binding group for the development of new carbonic anhydrase inhibitors. Chem Commun (Camb), 48, 8838-40. https://doi.org/10.1039/c2cc34275h
- Di Micco S, Chini MG, Terracciano S, et al (2013). Structural basis for the design and synthesis of selective HDAC inhibitors. Bioorg Med Chem, 21, 3795-807. https://doi.org/10.1016/j.bmc.2013.04.036
- Di Micco S, Terracciano S, Bruno I, et al (2008). Molecular modeling studies toward the structural optimization of new cyclopeptide-based HDAC inhibitors modeled on the natural product FR235222. Bioorg Med Chem, 16, 8635-42. https://doi.org/10.1016/j.bmc.2008.08.003
- Dubois F, Caby S, Oger F, et al (2009). Histone deacetylase inhibitors induce apoptosis, histone hyperacetylation and up-regulation of gene transcription in Schistosoma mansoni. Mol Biochem Parasitol, 168, 7-15. https://doi.org/10.1016/j.molbiopara.2009.06.001
- Duo J, Ma Y, Wang G, Han X, Zhang C (2013). Metformin synergistically enhances antitumor activity of histone deacetylase inhibitor trichostatin a against osteosarcoma cell line. DNA Cell Biol, 32, 156-64. https://doi.org/10.1089/dna.2012.1926
- Ellis L, Pan Y, Smyth GK, et al (2008). Histone deacetylase inhibitor panobinostat induces clinical responses with associated alterations in gene expression profiles in cutaneous T-cell lymphoma. Clin Cancer Res, 14, 4500-10. https://doi.org/10.1158/1078-0432.CCR-07-4262
- Eymin B, Leduc C, Coll JL, Brambilla E, Gazzeri S (2003). p14ARF induces G2 arrest and apoptosis independently of p53 leading to regression of tumours established in nude mice. Oncogene, 22, 1822-35. https://doi.org/10.1038/sj.onc.1206303
- Feng T, Wang H, Su H, et al (2013). Novel N-hydroxyfurylacrylamide-based histone deacetylase (HDAC) inhibitors with branched CAP group (Part 2). Bioorg Med Chem, 21, 5339-54. https://doi.org/10.1016/j.bmc.2013.06.009
- Finnin MS, Donigian JR, Cohen A, et al (1999). Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors. Nature, 401, 188-93. https://doi.org/10.1038/43710
- Hoshino I, Matsubara H (2010). Recent advances in histone deacetylase targeted cancer therapy. Surg Today, 40, 809-15. https://doi.org/10.1007/s00595-010-4300-6
- Hoshino I, Matsubara H, Akutsu Y, et al (2007). Gene expression profiling induced by histone deacetylase inhibitor, FK228, in human esophageal squamous cancer cells. Oncol Rep, 18, 585-92.
- Hrebackova J, Poljakova J, Eckschlager T, et al (2009). Histone deacetylase inhibitors valproate and trichostatin A are toxic to neuroblastoma cells and modulate cytochrome P450 1A1, 1B1 and 3A4 expression in these cells. Interdiscip Toxicol, 2, 205-10.
- Ito N, Sawa H, Nagane M, et al (2001). Inhibitory effects of sodium butyrate on proliferation and invasiveness of human glioma cells. Neurosurgery, 49, 430-6, 436-7.
- Kerr JS, Galloway S, Lagrutta A, et al (2010). Nonclinical safety assessment of the histone deacetylase inhibitor vorinostat. Int J Toxicol, 29, 3-19. https://doi.org/10.1177/1091581809352111
- Li XH, Huang ML, Wang SM, Wang Q (2013). Selective inhibition of bicyclic tetrapeptide histone deacetylase inhibitor on HDAC4 and K562 leukemia cells. Asian Pac J Cancer Prev, 14, 7095-100. https://doi.org/10.7314/APJCP.2013.14.12.7095
- Li Y, Liu B, Fukudome EY, et al (2011). Identification of citrullinated histone H3 as a potential serum protein biomarker in a lethal model of lipopolysaccharide-induced shock. Surgery, 150, 442-51. https://doi.org/10.1016/j.surg.2011.07.003
- Miller CP, Ban K, Dujka ME, et al (2007). NPI-0052, a novel proteasome inhibitor, induces caspase-8 and ROS-dependent apoptosis alone and in combination with HDAC inhibitors in leukemia cells. Blood, 110, 267-77. https://doi.org/10.1182/blood-2006-03-013128
- Nelson HH, Marsit CJ, Christensen BC, et al (2012). Key epigenetic changes associated with lung cancer development: results from dense methylation array profiling. Epigenetics, 7, 559-66. https://doi.org/10.4161/epi.20219
- Osada H, Tatematsu Y, Sugito N, Horio Y, Takahashi T (2005). Histone modification in the TGFbetaRII gene promoter and its significance for responsiveness to HDAC inhibitor in lung cancer cell lines. Mol Carcinog, 44, 233-41. https://doi.org/10.1002/mc.20135
- Shinji C, Maeda S, Imai K, et al (2006). Design, synthesis, and evaluation of cyclic amide/imide-bearing hydroxamic acid derivatives as class-selective histone deacetylase (HDAC) inhibitors. Bioorg Med Chem, 14, 7625-51. https://doi.org/10.1016/j.bmc.2006.07.008
- Sriraksa R, Limpaiboon T (2013). Histone deacetylases and their inhibitors as potential therapeutic drugs for cholangiocarcinoma - cell line findings. Asian Pac J Cancer Prev, 14, 2503-8. https://doi.org/10.7314/APJCP.2013.14.4.2503
- Takai N, Kira N, Ishii T, et al (2011). Novel chemotherapy using histone deacetylase inhibitors in cervical cancer. Asian Pac J Cancer Prev, 12, 575-80.
- Wanczyk M, Roszczenko K, Marcinkiewicz K, et al (2011). HDACi--going through the mechanisms. Front Biosci (Landmark Ed), 16, 340-59. https://doi.org/10.2741/3691
- Xia G, Schneider-Stock R, Diestel A, et al (2008). Helicobacter pylori regulates p21 (WAF1) by histone H4 acetylation. Biochem Biophys Res Commun, 369, 526-31. https://doi.org/10.1016/j.bbrc.2008.02.073
- Yoshioka T, Yogosawa S, Yamada T, Kitawaki J, Sakai T (2013). Combination of a novel HDAC inhibitor OBP-801/YM753 and a PI3K inhibitor LY294002 synergistically induces apoptosis in human endometrial carcinoma cells due to increase of Bim with accumulation of ROS. Gynecol Oncol, 129, 425-32. https://doi.org/10.1016/j.ygyno.2013.02.008
피인용 문헌
- Ethanol but not Aqueous Extracts of Tubers of Sauromatum Giganteum(Engl.) Cusimano and Hett Inhibit Cancer Cell Proliferation vol.15, pp.24, 2015, https://doi.org/10.7314/APJCP.2014.15.24.10613
- Synthesis, Biological Evaluation, and Computer-Aided Drug Designing of New Derivatives of Hyperactive Suberoylanilide Hydroxamic Acid Histone Deacetylase Inhibitors vol.86, pp.4, 2015, https://doi.org/10.1111/cbdd.12554